| Line Item | 2025-10-24 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.96B | +4.5% | +6.6% |
| Cost of Revenue | $3.06B | +2.0% | +3.9% |
| R&D Expense | $754.0M | +3.9% | +8.2% |
| SG&A Expense | $2.96B | +5.7% | +7.5% |
| Operating Income | $1.69B | +16.7% | +5.7% |
| Pre-tax Income | $1.60B | +22.7% | +2.4% |
| Income Tax | $215.0M |
| Line Item | 2025-10-24 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.28B | +0.7% | -8.0% |
| Short-term Investments | $7.04B | +2.9% | +6.8% |
| Accounts Receivable | $6.39B | +2.0% | +2.1% |
| Inventory | $6.16B | +4.6% | +12.4% |
| Current Assets | $24.00B | +3.3% | +6.9% |
| Total Assets |
| Line Item | 2025-10-24 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.01B | +85.0% | — |
| Capital Expenditures | $972.0M | +92.9% | — |
| Investing Cash Flow | -$1.20B | -67.0% | — |
| Financing Cash Flow | -$1.78B | -28.6% | — |
| Free Cash Flow | $1.04B | +78.3% | — |
| -15.7% |
| -23.5% |
| Net Income | $1.37B | +32.1% | +8.2% |
| EPS (Basic) | $1.07 | +32.1% | +8.1% |
| EPS (Diluted) | $1.07 | +32.1% | +8.1% |
| $91.35B |
| +0.4% |
| +1.4% |
| Current Liabilities | $9.94B | -13.8% | -18.5% |
| Long-term Debt | $27.68B | +5.7% | +12.5% |
| Total Liabilities | $42.49B | -0.8% | +2.8% |
| Stockholders' Equity | $48.65B | +1.6% | +0.3% |